Versor Investments LP Royalty Pharma PLC Transaction History

Versor Investments LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$26.26 - $29.9 $804,002 - $915,448	-30,617 Reduced 77.4%	8,942 $235,000
Q1 2024 May 13, 2024	BUY	$27.46 - $31.33 $508,476 - $580,137	18,517 Added 88.0%	39,559 $1.2 Million
Q4 2023 Feb 07, 2024	BUY	$26.21 - $29.22 $551,510 - $614,847	21,042 New	21,042 $591,000
Q2 2023 Aug 07, 2023	BUY	$29.6 - $36.56 $325,984 - $402,635	11,013 Added 48.3%	33,813 $1.04 Million
Q1 2023 May 05, 2023	SELL	$32.77 - $39.4 $327,372 - $393,606	-9,990 Reduced 30.47%	22,800 $821,000
Q4 2022 Jan 30, 2023	BUY	$39.17 - $44.04 $528,403 - $594,099	13,490 Added 69.9%	32,790 $1.3 Million
Q3 2022 Oct 25, 2022	BUY	$39.88 - $44.65 $769,684 - $861,745	19,300 New	19,300 $775,000
Q2 2022 Jul 27, 2022	SELL	$37.53 - $44.22 $290,707 - $342,528	-7,746 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$37.46 - $42.44 $76,268 - $86,407	-2,036 Reduced 20.81%	7,746 $302,000
Q4 2021 Feb 08, 2022	BUY	$35.17 - $42.48 $344,032 - $415,539	9,782 New	9,782 $390,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.